China survey reveals what R/R mantle cell lymphoma patients and doctors value after BTK failure—overall survival tops trade-offs despite CRS risk. Despite advances in recent years, treatment choices ...
Blood cancer patients treated with Nexcar19 - 'Made in India' CAR-T cancer therapy, available at a tenth of the cost of ...
Researchers at MIT have found a way to use a nontoxic antifreeze sugar to protect CAR-T cells from damage during storage and ...
Seoul St. Mary's Hospital is launching a clinical research program to test the effectiveness of autologous immune cell ...
Dr. Roberts said overall childhood cancer survival has climbed from less than 20% when St. Jude opened to about 80% today.
Hodgkin lymphoma survivors had nearly twice the mortality of the general United States population, with excess deaths across ...
Five-year survivors of Hodgkin lymphoma (HL) diagnosed during adulthood experience nearly twofold higher all-cause mortality ...
Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has submitted a supplemental application to ANVISA, the Brazilian health ...
The AACR roadmap spotlights LDCT screening, ctDNA MRD monitoring, and new NSCLC/SCLC therapies like DLL3 tarlatamab to close ...
Learn how modern cancer treatments like immunotherapy and CAR-T cells are shifting the risk of opportunistic infections from ...
A five-year funding award led by Mohamed Sorror, MD, MS, from the Patient-Centered Outcomes Research Institute (PCORI) will support three national randomized trials.
Ethiopia Reports Promising Pediatric Hodgkin Lymphoma Treatment Outcomes - CANCaRe Africa / CANCaRe Africa, cancer, cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results